Mobile

Study of Pembrolizumab Maintenance Following First-Line Platinum Based Chemotherapy in Patients with Metastatic Squamous - Non-Small Cell Lung Cancer (sNSCLC) Studie zur Untersuchung einer ...

Mise à jour : Il y a 4 ans
Référence : EUCTR2015-001123-22

Study of Pembrolizumab Maintenance Following First-Line Platinum Based Chemotherapy in Patients with Metastatic Squamous - Non-Small Cell Lung Cancer (sNSCLC) Studie zur Untersuchung einer Erhaltungstherapie durch Pembrolizumab nach einer platinbasierten Erstlinientherapie bei Patienten mit metastasierten, nicht-kleinzelligen Plattenepithelkarzinom der Lunge

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To investigate the efficacy of Pembrolizumab vs. placebo in terms of progression-free survival in patients with metastatic squamous, non-small cell lung cancer.

Critère d'inclusion

  • Patients with stage IV metastatic squamous non-small cell lung cancer

Liens